Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (431-440 of 491) with videos related to

Pageof 50
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2026
GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical OutcomesBenedikt Silvester Hofer, Thomas Perkmann, Ksenia Brusilovskaya, et al.
EMBO Reports|November 23, 2020
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesisValentina C Sladky, Katja Knapp, Tamas G Szabo, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Archives of Toxicology|August 13, 2022
Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicityReham Hassan, Adrian Friebel, Lisa Brackhagen, et al.
Hepatology Communications|October 21, 2025
The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic reviewChiara Becchetti, Elton Dajti, Grace L Su, et al.
JHEP Reports : Innovation in Hepatology|March 28, 2026
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort studyMichael Schwarz, Marlene Hintersteininger, Caroline Schwarz, et al.
Hepatology (Baltimore, Md.)|July 14, 2020
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver DiseaseGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Annals of Surgical Oncology|June 19, 2024
Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular CarcinomaDavid Pereyra, Mattias Mandorfer, Jonas Santol, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2025
Prevalence of Fibrosis and Applicability of Lab-based Noninvasive Tests From Primary to Tertiary CareGeorg Semmler, Paul Thöne, Jan Embacher, et al.
Pageof 50

Showing results (431-440 of 491) with videos related to

Sort By:
Pageof 50
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2026
GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical OutcomesBenedikt Silvester Hofer, Thomas Perkmann, Ksenia Brusilovskaya, et al.
EMBO Reports|November 23, 2020
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesisValentina C Sladky, Katja Knapp, Tamas G Szabo, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Archives of Toxicology|August 13, 2022
Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicityReham Hassan, Adrian Friebel, Lisa Brackhagen, et al.
Hepatology Communications|October 21, 2025
The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic reviewChiara Becchetti, Elton Dajti, Grace L Su, et al.
JHEP Reports : Innovation in Hepatology|March 28, 2026
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort studyMichael Schwarz, Marlene Hintersteininger, Caroline Schwarz, et al.
Hepatology (Baltimore, Md.)|July 14, 2020
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver DiseaseGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Annals of Surgical Oncology|June 19, 2024
Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular CarcinomaDavid Pereyra, Mattias Mandorfer, Jonas Santol, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2025
Prevalence of Fibrosis and Applicability of Lab-based Noninvasive Tests From Primary to Tertiary CareGeorg Semmler, Paul Thöne, Jan Embacher, et al.
Pageof 50